Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Analyst action - healthcare

Published 11/06/2017, 09:21 AM
Updated 11/06/2017, 09:21 AM
© Reuters.  Analyst action - healthcare
  • OrthoPediatrics (Pending:KIDS) initiated with Buy rating and $23 (11% upside) by Stifel. Initiated at Outperform by William Blair.
  • Rigel Pharmaceuticals (NASDAQ:RIGL) initiated with Buy rating and $7 (80% upside) price target by H.C. Wainwright.
  • SpringBank Pharmaceuticals (NASDAQ:SBPH) initiated with Buy rating and $30 (91% upside) by B. Riley FBR.
  • Bluebird bio (NASDAQ:BLUE) downgraded to In-line (Neutral) by Evercore ISI.
  • Tetraphase Pharmaceuticals (NASDAQ:TTPH) price target raised to $17 from $15 by H.C. Wainwright.
  • Five Prime Therapeutics (NASDAQ:FPRX) price target raised to $50 from $41 by RBC Capital Markets.
  • VBL Therapeutics (NASDAQ:VBLT) price target raised to $25 from $20 by Chardan Capital Markets.
  • AmerisourceBergen (NYSE:ABC) price target lowered to $86 from $93 citing near-term sentiment toward the group and risk associated with a potential entry by Amazon (NASDAQ:AMZN).
  • Obalon Therapeutics (NASDAQ:OBLN) price target lowered to $15 from $20 by BTIG Research.
  • HCA price target lowered to $81 from $87 by Citigroup (NYSE:C).
  • Teva Pharmaceutical Industries (NYSE:TEVA) price target lowered to $14 from $20 by Susquehanna.
  • Source: Bloomberg
  • Now read: Teva: New CEO Starts Work


Original article

Latest comments

Welcome,let’s see what will happen
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.